Congressional efforts to amend the Federal Food, Drug and Cosmetic Act and to limit the FDA’s statutory authority in regulating clinical and health software are not restricted to the House of…


Congressional efforts to amend the Federal Food, Drug and Cosmetic Act and to limit the FDA’s statutory authority in regulating clinical and health software are not restricted to the House of…